Postdoc, Andrej Shevchenko's lab , biological mass spectrometry, MPI-CBG, Dresden
This generic project is intended to be a forum for all LiSyM partner and external stakeholders interested in participating in the BMBF initiative LiSyM-Krebs.
Organisms: Not specified
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. LiSyM-EMI looks into the transition from steatosis to non-alcoholic steatohepatitis (NASH) as the disease-defining moment in NAFLD. A systems analysis of these early disease events will be performed to elucidate the molecular mechanisms that trigger disease establishment.
Date Published: 20th Oct 2018
Journal: TrAC Trends in Analytical Chemistry
Date Published: 30th Jul 2018
Journal: Anal Chem
PubMed ID: 30004672
Citation: Anal Chem. 2018 Jul 30. doi: 10.1021/acs.analchem.8b02004.